Science
Scientists use CRISPR-Cas9 to prevent Fuchs’ corneal dystrophy in mice – Medical Xpress
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used…
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used start codon disruption with CRISPR-Cas9 gene editing to prevent Fuchs’ corneal dystrophy in mice. It is the first demonstrated…
Continue Reading
-
Noosa News19 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business20 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News22 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Business24 hours agoDividends from ASX 200 bank shares ‘looking very stretched’: expert